Increasing government initiatives to promote the use of Point of Care Testing products and the rise in the geriatric population are driving the demand of the market.
iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
North America was the largest region in the home health care and residential nursing care services market in 2017, accounting for above 41% market share. The USA was the largest country in the market in 2017, accounting for above 36% market share. Read Report https://www.thebusinessresearchcompany.com/report/home-health-care-and-residential-nursing-care-services-global-market-report-2018
The global D-dimer testing market size was valued at US$ 1.23 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing is driving the global D-dimers market.The D-dimer test is used to find out if the patient is suffering from blood clotting disorder. The clotting of blood is very important, if the blood is not clotted, it may ooze out and the patient suffers from heavy blood loss.
Point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level.
This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8
A latest research report “Home Health Care And Residential Nursing Care Services Global Market Report” proposed by The Business Research Company provides a market summary on Market Analysis, Size, Trends and Growth. Read Full Report @ http://bit.ly/2XMvmfM Get Free Sample Copy @ http://bit.ly/2PzMtyA
Big Market Research presents a new package on "Spanish Endocrine Function Testing Market 2015: Hospitals, Commercial Labs, Ambulatory Care Centers" Read The Complete Report On : http://www.bigmarketresearch.com/spanish-endocrine-function-testing-2015-hospitals-commercial-labs-ambulatory-care-centers-market This new 271-page report provides a comprehensive analysis in the Spanish endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.
Prenatal screening for fetal defects has become a standard part of pregnancy medical care in the past couple of decades. Tests are typically conducted during the first half of pregnancy in order to detect a wide range of genetic and other disorders, and to give women the option of obtaining abortions if in case any defects are diagnosed. While some people believe this as a breakthrough in the prevention or eradications of diseases, it has significantly contributed to the improvement of society as a whole.
Big Market Reseach presents a new package on "Spanish Drugs of Abuse Testing Market 2015: Hospitals, Commercial Labs, Ambulatory Care Centers" Access The Full Report On : http://www.bigmarketresearch.com/spanish-drugs-of-abuse-testing-2015-hospitals-commercial-labs-ambulatory-care-centers-market This new 260-page report provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
The Report on “Point of Care POC Testing Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2015-emerging-point-of-care-poc-testing-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-supplier-shares-volume-and-sales-forecasts-for-300-tests-market/enquire-about-report
Point of care molecular diagnostics market is expected to reach a market value of USD 5.12 billion by 2027 growing at a CAGR of 12.9% in the forecast period of 2020-2027. The growing awareness regarding the testing methods among patients has been directly impacting the growth of point of care molecular diagnostics market.
Avail more information from Sample Brochure of report @ http://tinyurl.com/gre5az9 This new 1,230-page report contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies. Read analysis @ http://tinyurl.com/jklw5v3
Avail more information from Sample Brochure of report @ http://tinyurl.com/jqxmmph The “2016-2020 Emerging EU5 Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers---Competitive Strategies, Country Volume and Sales Segment Forecasts” report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country. Check complete report @ http://tinyurl.com/h52nqrv
Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/infectious-diagnostics-rapid-and-point-of-care-tests-pipeline-review-2015-market/enquire-about-report
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
The food safety testing market is anticipated to surpass USD 16 billion in the forecast period. The market is expected to show a healthy growth at a CAGR of 7.5%.
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
The global endocrine testing market was valued at US$6 billion in 2014 and is estimated to reach near about US$13 bn by 2023 at a CAGR of 8.8% from 2015 to 2023.
This 340-page report contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Read more: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-point-of-care-poc-lipid-testing-supplier-shares-and-country-forecasts-market
Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-point-of-care-poc-infectious-disease-testing-supplier-shares-and-country-forecasts-market Research Beam’s report on 2015-2019 Future Horizons and Growth Strategies in the US Point-of-Care/POC Infectious Disease Testing Market: Supplier Shares and Country Forecasts” contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
The global D-dimer testing market size was valued at US$ 1.23 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing is driving the global D-dimers market.The D-dimer test is used to find out if the patient is suffering from blood clotting disorder. The clotting of blood is very important, if the blood is not clotted, it may ooze out and the patient suffers from heavy blood loss.
The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.
The global point of care diagnostics market was valued at US$ 17,886.3 Mn 2018 and is expected to reach US$ 30,175.3 Mn 2026, growing at a CAGR of 6.8% during the forecast period.
Bharat Book Present"Coagulation Diagnostic Testing Market" which encompasses both laboratory and point of care (POC) testing, will continue to be one of the most important segments of the in vitro diagnostics market for the foreseeable future.
The hemoglobin testing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 9.18% in the above mentioned forecast period. https://www.databridgemarketresearch.com/reports/global-hemoglobin-testing-market
Testing, Inspection and Certification Market by Service (Testing, Inspection, Certification), Sourcing Type (In-House and Outsourced), Application (Consumer Goods and Retail, Construction and Infrastructure), and Geography
Data Bridge Market Research analyses that the point of care molecular diagnostics market is expected to undergo a CAGR of 13.40% during the forecast period https://www.databridgemarketresearch.com/reports/global-point-of-care-molecular-diagnostics-market
The Global HIV Diagnosis Market is projected to grow from USD 3.12 billion in 2020 to USD 5.28 billion by 2026 at a CAGR of over 9.2% during the forecast period.
The global diabetes care devices market was valued at around $13 billion in 2017. Asia Pacific was the largest region in the diabetes care devices market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 20% market share.
Legionella testing is a diagnostic method utilized for the detection of legionella bacteria which causes legionellesis. This disease is generally characterized as being similar to pneumonia, which requires extreme care and in some severe cases hospitalization of the patient.
Major Players in the Blood Glucose Test Strips Market are F. Hoffmann-La Roche AG, LifeScan, Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Terumo Corporation Read more @ https://bit.ly/2RJEiW7
Legionella testing is a diagnostic method utilized for the detection of legionella bacteria which causes legionellesis. This disease is generally characterized as being similar to pneumonia, which requires extreme care and in some severe cases hospitalization of the patient.
Some of the common tests that are available with today’s physicians are skin-prick testing, intradermal testing, and oral for confirmatory allergy testing. These tests are critical where the history describes serious allergic reactions; risk assessments based on historical descriptions alone are not reliable. Most of these tests are usually performed under specialized hands in speciality clinics, because, positive test results are less likely to be determined as the time period increases.
The Global Pneumonia Testing Market Size was valued at $945 million in 2016, and is estimated to reach $ 1,754.3 million by 2023. Full Report: https://kbvresearch.com/pneumonia-testing-market/
The global hospitals and outpatient care centers market was valued at around $4 trillion in 2017. Asia Pacific was the largest region in the hospitals and outpatient care centers market in 2017, accounting for above 31% market share. The USA was the largest country in the market in 2017, accounting for 23% market share.
The Asian home healthcare market is expected to reach USD 62.32 Billion by 2020 from USD 39.07 Billion in 2015, at a CAGR of 9.8% during the forecast period.
The diabetes care devices market size is expected to reach nearly $35 billion in 2021, growing at a CAGR of slightly more than 7% during the forecast period. Download A sample @ http://bit.ly/2Hg4IH8
"European Drugs of Abuse Testing Market 2015: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers" :BigMarketResearch.This Report Offers European Drugs of Abuse Testing Market-Size, Share, Forecast, Analysis, Technology, Sale, Supplier,Report and Research. To Get More Details Here @ http://www.bigmarketresearch.com/european-drugs-of-abuse-testing-2015-hospitals-commercial-labs-physician-offices-ambulatory-care-centers-market This new 300-page report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. Enquire About Report @ http://www.bigmarketresearch.com/report-enquiry/200023
According to #TechSci Research report, Global Rapid Test Kit Market stood at USD23.44 billion in 2020 and expected to grow at steady CAGR of 8.14% by 2026. Gain More Insight: https://bit.ly/3vEVaM0 Get Sample Report: https://bit.ly/37y0udo Press Release: https://bit.ly/3rzXsfK Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
VISIT HERE @ http://www.grandresearchstore.com/medical-devices/asian-home-health-care-market-by-product-bp-26-heart-rate-monitor-ovulation-kit-hiv-test-ecg-ekg-eeg-hearing-aids-ventilator-cane-walker-wheelchairs-services-rehabilitation-skilled-hospice-palliative-care-26-telehealth---forecasts-to-2020 This report provided by GrandResearchStore is about,The Asian home healthcare market is expected to reach USD 62.32 billion by 2020 from USD 39.07 billion in 2015, at a CAGR of 9.8% from 2015 to 2020. This market is segmented on the basis of products, services, telehealth, and countries. The Asian home telehealth market is expected to grow at the highest CAGR in the coming five years. Major factors contributing to the growth of the Asian home healthcare market include the rapidly growing aging population, increasing incidences of chronic diseases
Hemoglobin testing is the procedure of carrying out diagnostic tests to detect the levels of hemoglobin in the patient’s blood. Hemoglobin tests are used broadly by doctors as a part of their routine check-ups or to analyze a serious medical condition in the patient.
Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027
As per FMI’s analysis, the following players operate within the global zika virus testing market: EUROIMMUN US Inc. Creative Diagnostics Quest Diagnostics Artron Laboratories Inc. RapiGEN Inc.
Request a case study or sample research report @ https://precisionbusinessinsights.com/request-sample?product_id=17104 The Global Point of Care Diagnostics market size was valued at USD 27.66 billion in the year 2020 and is anticipated to record a CAGR of 3.25% during the overcast period 2021-2027. Competitive Analysis: Industry players follow some effective strategies to increase the revenue share in the market. A few of the prominent key players operating in point of care diagnostics market include Siemens AG (Germany), Abbott Laboratories, Inc.
Urinalysis tests refer to the range of tests that are conducted by taking urine as a sample for detecting symptoms for various kinds of diseases. It is considered one of the major tests for identifying any symptoms for liver diseases, diabetics, and kidney diseases. Urinalysis test consists of three types of test including chemical evaluation, microscopic examination, and gross examination.